Commodore Capital’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-635,000
| Closed | -$5.14M | – | 28 |
|
|
2023
Q1 | $5.14M | Sell |
635,000
-1,245,286
| -66% | -$10.1M | 0.78% | 26 |
|
|
2022
Q4 | $29.6M | Sell |
1,880,286
-530,336
| -22% | -$8.35M | 4.46% | 7 |
|
|
2022
Q3 | $37.9M | Hold |
2,410,622
| – | – | 6.1% | 7 |
|
|
2022
Q2 | $33.7M | Buy |
2,410,622
+95,974
| +4% | +$1.34M | 7.12% | 6 |
|
|
2022
Q1 | $39.9M | Sell |
2,314,648
-357,698
| -13% | -$6.17M | 8.91% | 2 |
|
|
2021
Q4 | $38.9M | Buy |
2,672,346
+482,055
| +22% | +$7.01M | 9% | 3 |
|
|
2021
Q3 | $39.4M | Buy |
2,190,291
+521,304
| +31% | +$9.38M | 10.39% | 2 |
|
|
2021
Q2 | $29.3M | Buy |
1,668,987
+640,903
| +62% | +$11.3M | 10.21% | 1 |
|
|
2021
Q1 | $25.9M | Sell |
1,028,084
-308,191
| -23% | -$7.77M | 10.32% | 1 |
|
|
2020
Q4 | $8.65M | Buy |
+1,336,275
| New | +$8.65M | 4.7% | 7 |
|